Catatonia. II. Treatment with lorazepam and electroconvulsive therapy

Acta Psychiatrica Scandinavica

Volumn 93, Issue 2, 1996, Pages 137-143

  Bush, G ^a,b   Fink, M ^a   Petrides, G ^a   Dowling, F ^a   Francis, A ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Catatonia; Electroconvulsive therapy; Lorazepam; Motor disorder; Rating scale

Indexed keywords

LORAZEPAM;

ADULT; ARTICLE; CATATONIA; CLINICAL ARTICLE; CLINICAL TRIAL; ELECTROCONVULSIVE THERAPY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029995097     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb09815.x     Document Type: Article

References (75)

1. KAHLBAUM KL. Catatonia. (Levi Y, Pridon T, trans.) Baltimore, MD: Johns Hopkins University Press, 1973.
2. MAHENDRA B. Where have all the catatonics gone? [editorial]. Psychol Med 1981: 11: 669-671.
3. KRAEPELIN EA. Lectures on clinical psychiatry. London: Bailliere, Tindall and Cox, 1904.
4. BLEULER E. Dementia praecox or the group of schizophrenias (Zinkin J, trans.). New York, NY: International University Press, 1950.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd edn. Washington, D.C: American Psychiatric Association, 1980.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd edn, revised. Washington, D.C: American Psychiatric Association, 1987.
7. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
8. ABRAMS R, TAYLOR MA. Catatonia: a prospective clinical study. Arch Gen Psychiatry 1976: 33: 579-581.
9. BARNES MP, SAUNDERS M, WALLS TJ. et al. The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry 1986: 49: 991-996.
10. RIES RK. DSM-III implications of the diagnoses of catatonia and bipolar disorder. Am J Psychiatry 1985: 142: 1471-1474.
11. GELENBERG AJ. The catatonic syndrome. Lancet 1976: 2: 1339-1341.
12. WILCOX JA, NASRALLAH HA. Organic factors in catatonia. Br J Psychiatry 1986: 149: 782-784.
13. FINK M, TAYLOR MA. Catatonia: a separate category in DSM-IV? Integr Psychiatry 1991: 7: 2-10.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, D.C: American Psychiatric Association, 1994.
15. LOHR JB, WISNIEWSKI AA. Movement disorders: a neuropsychiatric approach. New York, NY: The Guilford Press, 1987.
16. TAYLOR MA. Catatonia: a review of a behavioral neurologic syndrome. Neuropsychiatr Neuropsychol Behav Neurol 1990: 3: 48-72.
17. ROGERS D. Motor disorder in psychiatry: towards a neurological psychiatry. Chichester: John Wiley and Sons, 1992.
18. FINK M, BUSH G, FRANCIS A. Catatonia: a treatable disorder, occasionally recognized. Direct Psychiatry 1993: 13: 1-7.
19. JOHNSON J. Catatonia: the tension insanity. Br J Psychiatry 1993: 162: 733-738.
20. BENEGAL V, HINGORANI S, KHANNA S. Idiopathic catatonia: validity of the concept. Psychopathol 1993: 26: 41-46.
21. PATAKI J, ZERVAS IM, JANDORF L. Catatonia in a university inpatient service (1985-1990). Convuls Ther 1992: 8: 163-173.
22. ROSEBUSH PI, HILDEBRAND AM, FURLONG BG et al. Catatonic syndrome in a general psychiatric population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990: 51: 357-362.
23. KRAEPELIN EA. Psychiatry: a textbook for students and physicians. Canton, MA: Watson Publishing International, 1990.
24. MORRISON JR. Catatonia: retarded and excited types. Arch Gen Psychiatry 1973: 28: 39-41.
25. HALL JN. Ward rating scales for long-stay patients: a review. Psychol Med 1980: 10: 277-288.
26. TAYLOR MA, ABRAMS R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry 1973: 29: 520-522.
27. UNGVARI GA, LEUNG CM, WONG MK, LAU J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 1994: 89: 285-288.
28. ROBINS E, GUZE SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970: 126: 983-987.
29. KITAMURA T, OKAZAKI Y, FUJINAWA A et al. Symptoms of psychoses - a factor analytic study. Br J Psychiatry 1995: 166: 236-40.
30. ABRAMS R, TAYLOR MA, STOLUROW KA. Catatonia and mania: patterns of cerebral dysfunction. Biol Psychiatry 1979: 14: 111-117.
31. JOHNSON J. Stupor: a review of 25 cases. Acta Psychiatr Scand 1984: 70: 370-377.
32. Stoudemire A. The differential diagnosis of catatonic states. Psychosomatics 1982: 23: 245-252.
33. RAICHMAN JA, MARTIN RL, STILLINGS WA. Catatonic stupor: a diagnostically non-specific but distinct syndrome. J Clin Psychiatry 1981: 42: 477-478.
34. BLECKWENN WJ. Narcosis as therapy in neuropsychiatric conditions. J Am Med Assoc 1930: 95: 1168-1176.
35. FRICCHIONE GL, CASSEM NH, HOOBERMAN D et al. Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983: 3: 338-342.
36. SALAM SA, PILLAI AK, BERESFORD TP. Lorazepam for psychogenic catatonia. Am J Psychiatry 1987: 144: 1082-1083.
37. WALTER-RYAN WG. Treatment for catatonic symptoms with intramuscular lorazepam. J Clin Psychopharmacol 1985: 5: 123-124.
38. VINOGRADOV S, REISS AL. Use of lorazepam in treatment-resistant catatonia. J Clin Psychopharmacol 1986: 6: 323-324.
39. GREENFIELD D, CONRAD C, KINCARE P et al. Treatment of catatonia with low-dose lorazepam. Am J Psychiatry 1987: 144: 1224-1225.
40. CASEY DA. IV lorazepam in psychogenic catatonia [letter]. J Clin Psychopharmacol 1987: 7: 360.
41. UNGVARI GA, RANKIN JF. Lorazepam monotherapy for catatonia stupor. J Clin Psychopharmacol 1989: 9: 154.
42. HARRIS D, MENZA MA. Benzodiazepines and catatonia: a case report. Can J Psychiatry 1989: 34: 725-727.
43. WETZEL H, HEUSER I, BENKERT O. Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro-15-1788. J Nerv Ment Dis 1987: 175: 240-242.
44. CREMONA-BARBARO A. Neuroleptic-induced catatonic symptoms. Br J Psychiatry 1983: 142: 98-99.
45. MCEVOY JP, LOHR JB. Diazepam for catatonia. Am J Psychiatry 1984: 141: 284-285.
46. DELISLE JD. Catatonia unexpectedly reversed by midazolam. Am J Psychiatry 1991: 148: 809.
47. MEDUNA L. Die Konvulsionstherapie der schizophrenia. Halle: Carl Marhold, 1937.
48. FINK M. Meduna and the origins of convulsive therapy. Am J Psychiatry 1984: 141: 1034-1041.
49. MORRISON JR. Catatonia: diagnosis and management. Hosp Commun Psychiatry 1975: 26: 91-94.
50. FRICCHIONE GL, KAUFMAN LD, GRUBER BL et al. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Am J Med 1990: 88: 442-443.
51. BREAKEY WR, KALA AK. Typhoid catatonia responsive to ECT. Br Med J 1977: 2: 357-359.
52. ROHLAND BM, CARROLL BT, JACOBY RG. ECT in the treatment of the catatonic syndrome. J Affect Dis 1993: 29: 255-261.
53. American Psychiatric Association. The practice of electroconvulsive therapy: recommendations for treatment, training and privileging. Washington DC: American Psychiatric Association, 1990.
54. ABRAMS R. Electroconvulsive therapy. 2nd edn. New York: Oxford University Press, 1992.
55. CALEV A, FINK M, PETRIDES G et al. Caffeine pretreatment enhances clinical efficacy and reduces cognitive effects of electroconvulsive therapy. Convulsive Therapy 1993: 9: 95-100.
56. CAROFF S, MANN SC, LAZARUS A et al. Neuroleptic malignant syndrome: diagnostic issues. Psychiatr Ann 1991: 21: 130-147.
57. CARROLL BT. Catatonia on the consultation-liaison service. Psychosomatics 1992: 33: 310-315.
58. CASTILLO E, RUBIN RT, HOLSBOER-TRACHSLER E. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry 1989: 146: 3, 324-328.
59. FRICCHIONE GL. Neuroleptic catatonia and its relationship to psychogenic catatonia. Biol Psychiatry 1985: 20: 304-313.
60. WHITE DAC. Catatonia and the neuroleptic malignant syndrome - a single entity? Br J Psychiatry 1992: 161: 558-560.
61. WHITE DAC, ROBINS AH. Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991: 158: 419-421.
62. KONTAXAKIS VP, VAIDAKIS NM, CHRISTODOULOU GN et al. (1990) Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome. Neuropsychobiol 1990: 23: 38-40.
63. STOUDEMIRE A, LUTHER JS. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment. Int J Psychiatry Med 1984: 14: 57-63.
64. BONNER CA, KENT GH. Overlapping symptoms in catatonic excitement and manic excitement. Am J Psychiatry 1936: 92: 1311-1322.
65. STAUDER KH. Die tödliche Katatonie. Arch Psychiatr Nervenkr 1934: 102: 614-634.
66. MANN SC, CAROFF SN, BLEIER HR et al. Lethal catatonia. Am J Psychiatry 1986: 143: 1374-1381.
67. PHILBRICK KL, RUMMANS TA. Malignant catatonia. J Neuropsychiatry 1994: 6: 1-13.
68. ARNOLD OH, STEFAN H. Untersuchungen zur Frage der akuten tödlichen Katatonie. Wien Z Nervenheilkunde Deren Grenzgebiete 1952: 4: 235-258.
69. FRICCHIONE GL. Catatonia: a new indication for benzodiazepines? Biol Psychiatry 1989: 26: 761-765.
70. PEARLMAN C. Electroconvulsive therapy: current concepts. Gen Hosp Psychiatry 1991: 13: 128-137.
71. GELENBERG AJ. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry 1977: 34: 947-950.
72. COOPER JR, BLOOM FE, ROTH RH. The biochemical basis of neuropharmacology. 6th edn. New York: Oxford University Press, 1991.
73. DEVENAND DP, SCHAPIRA B, PETTY F et al. Effects of electroconvulsive therapy on plasma GABA. Convuls Ther 1995: 11: 3-13.
74. LINDEMANN E. Psychological changes in normal and abnormal individuals under the influence of sodium amytal. Am J Psychiatry 1932: 88: 1083-1091.
75. RANKEL HW, RANKEL LE. Carbamazepine in the treatment of catatonia. Am J Psychiatry 1988: 145: 361-362.